Benzoyl peroxide (BPO) has been used as a topical acne treatment since the 1960s and remains, six decades later, the most effective over-the-counter acne ingredient available. It outperforms salicylic acid for inflammatory acne, works through a different mechanism than retinoids, and — crucially — does not generate antibiotic resistance. Yet it is also one of the most misused ingredients in skincare: applied at unnecessarily high concentrations, slathered over the whole face, and abandoned within days because of the dryness and irritation it causes when used incorrectly. Getting benzoyl peroxide right means understanding what it actually does and matching the application approach to what the evidence recommends.
Benzoyl peroxide works by releasing free oxygen radicals that kill Cutibacterium acnes bacteria directly, making it bactericidal rather than bacteriostatic. It also has mild keratolytic (pore-clearing) activity. 2.5% is as effective as 10% for most people with significantly less irritation — start low. Apply as a spot treatment or thin layer to acne-prone areas only, not the whole face. It bleaches fabric and can oxidise vitamin C, so timing and placement matter.
BPO's mechanism is oxidative. When applied to skin, it decomposes and releases benzoic acid and oxygen free radicals. Those radicals are lethal to Cutibacterium acnes — the anaerobic bacterium that colonises sebaceous follicles and triggers inflammatory acne — because the anaerobic environment those bacteria depend on is destroyed by the oxygen burst. This is a direct bactericidal effect: BPO kills the bacteria outright rather than merely inhibiting their growth (bacteriostatic), which is what topical antibiotics like clindamycin do.
This distinction has significant clinical implications. Because BPO's killing mechanism is purely oxidative — not dependent on specific bacterial metabolic pathways — C. acnes cannot develop resistance to it. Decades of widespread use have produced no resistant strains. Topical antibiotics, by contrast, face significant and growing resistance problems, particularly for clindamycin and erythromycin. This is one reason dermatology guidelines now recommend combining topical antibiotics with benzoyl peroxide in any antibiotic regimen — BPO prevents resistance from developing even during antibiotic treatment.
Beyond its antibacterial action, BPO has mild keratolytic activity — it loosens the bonds between dead skin cells and helps clear the follicular plugs that become comedones. This is weaker than dedicated keratolytic agents like salicylic acid (BHA), but it contributes to BPO's effectiveness against both comedonal and inflammatory acne.
BPO is available OTC in concentrations ranging from 2.5% to 10%. The persistent assumption that higher concentrations work better is contradicted by the clinical evidence. A landmark 1986 study by Mills et al. and subsequent confirmatory trials have consistently shown that 2.5% BPO produces equivalent reductions in C. acnes counts and inflammatory lesions as 5% and 10% formulations, while producing significantly less dryness, peeling, and irritation. The bactericidal effect is not concentration-dependent in a clinically meaningful way above 2.5% — the follicle environment is saturated with sufficient oxygen radicals at that concentration to kill the target bacteria.
| Concentration | Efficacy vs 2.5% | Irritation Level | Best Use Case |
|---|---|---|---|
| 2.5% | Reference standard | Low | Daily use, sensitive or dry skin, starting out |
| 5% | Equivalent | Moderate | Tolerant skin, wash-off formats |
| 10% | Equivalent | High | Spot treatment only, short contact; not for daily leave-on use |
Start at 2.5% regardless of acne severity. If your skin tolerates it well after 4–6 weeks, stepping up to 5% is an option — but for most people, 2.5% used consistently and correctly is the long-term answer. The 10% products sold in many pharmacies are a legacy of the assumption that stronger equals better, and the evidence does not support using them as leave-on daily treatments.
BPO is formulated both as leave-on products (gels, creams, spot treatments) and as wash-off cleansers. For targeted acne treatment, leave-on is more effective — a brief contact time during cleansing does not allow sufficient penetration into the follicle for maximum bactericidal effect. Wash-off BPO cleansers are useful as a lower-irritation entry point, or as a body acne treatment (chest, back) where a leave-on gel is impractical, but they should not be considered equivalent to a leave-on formulation for facial acne.
The most common mistake with BPO is application method: spreading a thick layer across the entire face twice a day immediately on starting. This causes severe dryness, peeling, and redness that leads most people to quit before the ingredient has had time to work. The correct approach is considerably more measured.
Start with alternate-day application. Apply every other night for the first two weeks. This allows your skin to adjust to the oxidative activity without acute barrier disruption. After two weeks, if tolerance is good, move to daily use.
Use a pea-sized amount for the whole face, or spot-treat only. BPO should be applied as a thin layer to acne-prone zones, not a thick coat. For non-inflamed comedonal acne, a gentle BHA like salicylic acid is more targeted — reserve BPO for actively inflamed pimples and pustules, where its bactericidal action is most needed. Our guide to building a routine for acne-prone skin covers where BPO fits in a full routine.
Apply after cleansing, before moisturiser. BPO goes on clean, dry skin. Wait until skin is fully dry after cleansing — applying to damp skin increases penetration and irritation. Follow with a non-comedogenic moisturiser containing niacinamide or panthenol to buffer the barrier impact.
Use PM only if combining with other actives. BPO degrades in UV light (reducing its efficacy) and can make skin more photosensitive. Evening application is preferred. If you use a retinoid, do not apply BPO and retinoid on the same night — alternate them, or apply BPO as a spot treatment before retinoid rather than mixing them.
Benzoyl peroxide bleaches fabric. This is not a metaphor — it oxidises pigment molecules in textiles, permanently discolouring anything it contacts: pillowcases, towels, clothing. This is the number one reason people stop using it, and the frustration is entirely valid. Practical management: use white or old pillowcases and towels on nights you apply BPO, apply BPO early enough before bed that it has partially absorbed before your face contacts fabric, and apply BPO only to the target area rather than the whole face. Some people find PM application followed by allowing 20–30 minutes for absorption before bed is sufficient to avoid the worst bleaching.
BPO is an oxidising agent, and this creates genuine incompatibilities with a small number of other skincare actives:
Vitamin C (L-Ascorbic Acid): BPO oxidises L-ascorbic acid, rendering it less effective. If you use both, apply vitamin C in the AM and BPO in the PM — never in the same routine. Vitamin C derivatives (ascorbyl glucoside, ascorbyl tetraisopalmitate) are more stable and less vulnerable to oxidation, making them safer to use in the same routine.
Tretinoin and retinoids: Early studies suggested BPO degrades tretinoin, though more recent evidence suggests the interaction is less significant than initially thought. The bigger concern is cumulative irritation — both are potentially irritating, and combining them on the same night is unnecessarily aggressive. Use the Skin Stacker Compatibility Checker to map your full routine before stacking actives.
Salicylic acid: Not a chemical incompatibility, but applying both in the same routine is irritation-stacking. Use BPO for inflammatory lesions and salicylic acid for comedonal congestion — either alternate nights or apply BHA in AM and BPO in PM. See our guide to salicylic acid vs glycolic acid for context on what BHA is actually doing.
| Feature | Benzoyl Peroxide | Salicylic Acid (BHA) |
|---|---|---|
| Primary target | Inflammatory acne (papules, pustules, cysts) | Comedonal acne (blackheads, whiteheads, congestion) |
| Mechanism | Bactericidal — kills C. acnes directly | Keratolytic — exfoliates inside the follicle |
| Antibiotic resistance | None possible | N/A — not antibacterial |
| Irritation potential | High — dryness, peeling, redness | Moderate — mild peeling, possible purging |
| Bleaches fabric | Yes | No |
| Best for | Active inflamed breakouts | Chronic congestion, oily skin, blackheads |
| Use together? | Yes — alternating, AM/PM split. Not same application. | |